CatalystWireBeta

Final Results

In brief · summary, not quotable

14-month FY26 loss £5.2m; secured 100% project ownership, DFC US$4.84m funding commitment, exploitation permit granted.

Full year to 30 Jun 2026NowYear beforeChange
Operating profit (£5.1m) (£3.3m)
Profit before tax (£5.2m) (£14.2m)
Net income (£5.2m) (£14.2m)
Cash from operations (£2.1m) (£0.2m)
Cash £1.1m £0.0m +3788.0%

Figures as reported, converted to £ where needed – see all financials.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your HREE notes

Harena Rare Earths plc (LSE: HREE, OTCQB: CRMNF), the rare earths company focused on the Ampasindava ionic clay rare earth project in Madagascar (the "Ampasindava Project"), announces its audited results for the 14-month period ended 30 June 2026 (“FY 2026”).

A copy of the report and accounts for FY 2026 will be posted to shareholders shortly and will also be available on the Company's website at https://harenaresources.com/ and will also be available for inspection on the National Storage Mechanism at:

Subscribe to our news alert service: https://hree-l.investorhub.com/auth/signup

Chairman’s Statement

Dear Shareholders,

It gives me great pleasure to present Harena Rare Earths PLC’s (the “Company”, together with its subsidiaries the “Group”) Annual Report and Accounts for the year ended 30 June 2026, a year in which we took decisive steps to develop the Ampasindava Ionic Clay Rare Earth Project (the “Project”) in Madagascar and to strengthen the Group’s financial and technical platform for the work ahead.

In August 2025 we completed a restructuring of the Group’s holding of the Ampasindava Project, removing the prior 25% minority interest and meaning we now hold 100% ownership.

In January 2026 we completed the Project’s Pre-Feasibility Study. This was a pivotal milestone: it moved the Project to a more advanced stage of technical definition, with an indicative route to production, and it allowed us to move straight into the Definitive Feasibility Study (“DFS”) and associated environmental and social impact assessment (“ESIA”) workstreams that are now our principal technical focus.

Madagascar’s regulatory environment also improved markedly during the year. On 30 January 2026, following the political transition of October 2025, the Government of Madagascar lifted the 16-year moratorium on new mining permits across most mineral categories, including rare earths. The Directors believe this materially de-risks the regulatory pathway for our permit, and we have continued to engage directly and constructively with Madagascar’s Ministry of Mines throughout the year.

We demonstrated our ability to fund the business throughout the year, completing an institutional placing and subscription raising c.£1.2 million in August 2025, a further £450,000 strategic investment from RAB Capital in October 2025, and a £2.0 million equity placing from Greg Coffey and Matthew Press in February 2026. In November 2025 our shares also commenced trading on the OTCQB market in the United States under the ticker CRMNF, broadening our access to US investors consistent with our strategy of deepening engagement with the US market as the Project advances.

The Board was refreshed during the year. On 4 August 2025 Paul Richards joined the Board as a Non-Executive Director and I was appointed Non-Executive Chairman, becoming Executive Chairman from 1 October 2025. Paul and I bring a detailed understanding of the Ampasindava Project through our long history with it, and we are delighted to have the opportunity to work on it again alongside Allan’s technical expertise. On behalf of the Board, I would like to thank Cameron Pearce and Sam Quinn, who stepped down as Non-Executive Directors on the same day, for helping the Company complete its London Stock Exchange listing in March 2025.

We also strengthened the finance function during the year, appointing Jack Allardyce as interim Chief Financial Officer in January 2026 before confirming him as permanent CFO in April 2026. Jack brings substantial listed-company finance and capital markets experience to the Group as we move into a more capital-intensive phase of the Project’s development.

Since the year end, we have achieved what I regard as the most significant milestone in the Company’s history to date. On 21 July 2026 we signed a Project Development Funding Agreement (“PDFA”) with the U.S. International Development Finance Corporation (“DFC”), under which DFC has committed US$4.84 million towards permitting, environmental and social studies as we progress our Ampasindava proof-of-concept plant - DFC’s first mining investment in Madagascar and its first direct financial commitment to our Project. On 7 and 10 August 2026 DFC publicly announced the financing, and Harena was separately featured in a White House Critical Minerals Fact Sheet, providing further recognition of Ampasindava’s strategic relevance to U.S. critical-mineral supply-chain objectives.

On 12 October 2026 the Company announced that the Exploitation Permit for the Ampasindava Project had been formalised, following the signing of the Cahier des Charges Minières on 11 August 2026. The Company is now focused on obtaining the Environmental Permit and completing the Environmental and Social Management Plans, which are prerequisites to commencing infrastructure construction for the pilot phase.

Taken together, these developments - full ownership of a validated, economically robust project; an improving regulatory environment; a first-of-its-kind development finance commitment from the US government; and a demonstrated, diversified funding track record - have materially strengthened Harena’s position as it progresses Ampasindava through feasibility and permitting. Looking ahead, our priorities are to progress the DFS and ESIA, to complete the outstanding environmental permitting workstream, and to advance towards construction of our Demo Plant.

On behalf of the Board, I would like to thank our shareholders, partners in Madagascar and the United States, and the whole Harena team for their continued support and hard work. We enter the new financial year with real momentum and a clear path towards production.

Ivan Murphy

Executive Chairman

Consolidated Statement of Comprehensive Income for the period ended 30 June 2026

NotesYear ended 30 June 2026Year ended 30 June 2025
££
Administrative fees and other expenses5(5,070,957)(3,330,754)
Operating loss(5,070,957)(3,330,754)
Finance income80112
Listing costs11-(10,321,369)
Finance costs8(93,138)(535,277)
Loss before tax(5,164,015)(14,187,288)
Income tax10--
Loss after tax for the year attributable to owners of the parent(5,164,015)(14,187,288)
Other comprehensive income
Items that may be reclassified to profit or loss:
Exchange differences on translation of foreign operations127,86748,777
Total comprehensive loss for the year(5,036,148)(14,138,511)
Total comprehensive loss attributable to owners of Harena Rare Earths PLC(5,036,148)(14,138,511)
Total comprehensive loss attributable to non-controlling interests--
Total comprehensive loss for the period(5,036,148)(14,138,511)
Basic and diluted loss per share (pence)15(0.88)(10.82)

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Consolidated Statement of Financial Position as at 30 June 2026

Notes30 June 202630 June 2025
(restated)
££
Non-current assets
Other intangible assets142,192,5011,875,768
Total non-current assets2,192,5011,875,768
Current assets
Trade and other receivables18168,836196,289
Cash and cash equivalents191,105,16928,425
Total current assets1,274,005224,714
Total assets3,466,5062,100,482
Current liabilities
Loan note liability21677,654-
Trade and other payables20601,418612,314
Total current liabilities1,279,072612,314
Non-current liabilities
Loan note liability21-572,937
Total non-current liabilities-572,937
Total liabilities1,279,0721,185,251
Net assets2,187,434915,231
Equity
Share capital223,390,2902,033,422
Share premium225,396,9061,285,724
Merger reserve228,333,3338,333,333
Treasury shares22-36,000
Share option and warrant reserve221,973,701922,324
Share based payment reserve221,670,2511,831,310
Translation reserve22151,04623,179
Retained earnings(11,116,177)(6,284,822)
Reverse acquisition reserve22(7,611,916)(7,611,916)
Non-controlling Interest-346,677
Total equity2,187,434915,231

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Ivan James Bowen Murphy Andrew Paul Richards

Executive Chairman Non-Executive Director

Company Registration No.12557958

Company Statement of Financial Position as at 30 June 2026

Notes30 June 202630 June 2025
££
Non-current assets
Investment in subsidiary1610,000,00010,000,000
Loan to subsidiary172,290,6861,049,556
Total non-current assets12,290,68611,049,556
Current assets
Trade and other receivables18204,270168,816
Cash and cash equivalents19733,1251,991
Total current assets937,395170,807
Total assets13,228,08111,220,363
Current liabilities
Loan note liability21677,654-
Trade and other payables20428,068281,328
Total current liabilities1,105,722281,328
Non-current liabilities
Loan note liability21-608,725
Total non-current liabilities-608,725
Total liabilities1,105,722890,053
Net assets12,122,35910,330,310
Equity
Share capital223,390,2902,033,422
Share premium225,396,9061,285,724
Merger reserve228,333,3338,333,333
Treasury shares22-36,000
Share option and warrant reserve222,040,505989,127
Share based payment221,670,2511,831,310
Retained earnings(8,708,926)(4,178,606)
Total equity12,122,35910,330,310

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive Income in these financial statements. The loss after tax of the Company for the year was £4,516,303 (2025: loss of £2,941,414).

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Ivan James Bowen Murphy Andrew Paul Richards

Executive Chairman Non-Executive Director

Company Registration No.12557958

Consolidated Statement of Changes in Equity for the year ended 30 June 2026

Share capitalShare premiumTreasury sharesShare option & warrant reserveShare based payment reserveTranslation reserveReverse acquisition reserveMerger reservePre-acquisition reserveRetained earningsTotal Equity of ownersNon-controlling interestTotal equity
£££££££££££££
Balance as at 30 June 2024548,538----(25,598)--137,134(2,637,950)(1,977,876)346,677(1,631,199)
Loss for the period---------(14,187,288)(14,187,288)-(14,187,288)
Exchange differences on translation of foreign operations-----48,777----48,777-48,777
Total comprehensive loss-----48,777---(14,187,288)(14,138,511)-(14,138,511)
Transactions with owners
New shares issued (note 22)1,817,1728,745,70036,000-------10,598,872-10,598,872
FV adjustment (note 22)-(35,940)--------(35,940)-(35,940)
Share issue costs (note 22)-(12,500)--------(12,500)-(12,500)
Share based payment charge (note 23)---922,3241,831,310-----2,753,634-2,753,634
Settlement of subsidiary loan notes--------3,044,105-3,044,105-3,044,105
Reverse acquisition adjustments(332,288)921,797----(7,611,916)-(3,181,239)10,540,416336,770-336,770
Total transactions with owners1,484,8849,619,05736,000922,3241,831,310-(7,611,916)-(137,134)10,540,41616,684,941-16,684,941
Balance as at 30 June 2025 (as previously stated)2,033,4229,619,05736,000922,3241,831,31023,179(7,611,916)--(6,284,822)568,554346,677915,231
Prior period restatement (note 12)-(8,333,333)-----8,333,333-----
Restated balance as at 30 June 2025 (note 12)2,033,4221,285,72436,000922,3241,831,31023,179(7,611,916)8,333,333-(6,284,822)568,554346,677915,231

Consolidated Statement of Changes in Equity for the year ended 30 June 2026 (continued)

Share capitalShare premiumTreasury sharesShare option & warrant reserveShare based payment reserveTranslation reserveReverse acquisition reserveMerger reserveRetained earningsTotal Equity of ownersNon-controlling interestTotal equity
££££££££££££
Restated balance as at 30 June 20252,033,4221,285,72436,000922,3241,831,31023,179(7,611,916)8,333,333(6,284,822)568,554346,677915,231
Loss for the period--------(5,164,015)(5,164,015)-(5,164,015)
Exchange differences on translation of foreign operations-----127,867---127,867-127,867
Total comprehensive loss-----127,867--(5,164,015)(5,036,148)-(5,036,148)
Transactions with owners
New shares issued (note 22)1,350,8784,345,672-------5,696,550-5,696,550
Share issue costs (note 22)-(300,440)-------(300,440)-(300,440)
Settlement of treasury shares (note 22)5,99065,950(36,000)-----(14,017)21,923-21,923
Share based payment charge (note 23)---1,051,377(161,059)----890,318-890,318
Removal of non-controlling interest (note 2.2)--------346,677346,677(346,677)-
Total transactions with owners1,356,8684,111,182(36,000)1,051,377(161,059)---332,6606,655,028(346,677)6,308,351
Balance as at 30 June 20263,390,2905,396,906-1,973,7011,670,251151,046(7,611,916)8,333,333(11,116,177)2,187,434-2,187,434

The nature of the share option and warrant reserve, share base payment reserve, translation reserve and reverse acquisition reserves are described in the notes to financial statements.

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Company Statement of Changes in Equity for the year ended 30 June 2026

Share capitalShare premiumMerger reserveTreasury sharesShare option & warrant reserveShare based payment reserveRetained earningsTotal equity
££££££££
Balance as at 30 April 2024216,250921,797--17,422-(1,254,614)(99,145)
Loss for the period------(2,941,414)(2,941,414)
Total comprehensive income------(2,941,414)(2,941,414)
Transactions with owners
New shares issued (note 22)1,817,172412,3678,333,33336,000---10,598,872
FV adjustment (note 22)-(35,940)-----(35,940)
Share issue costs (note 22)-(12,500)-----(12,500)
Share based payment charge (note 23)----989,1271,831,310-2,820,437
Lapsed warrants----(17,422)-17,422-
Total transaction with owners1,817,172363,9278,333,33336,000971,7051,831,31017,42213,370,869
Restated balance as at 30 June 2025 (note 12)2,033,4221,285,7248,333,33336,000989,1271,831,310(4,178,606)10,330,310
Loss for the period------(4,516,303)(4,516,303)
Total comprehensive income------(4,516,303)(4,516,303)
Transactions with owners
New shares issued (note 22)1,348,3784,333,122-----5,681,500
Settlement of treasury shares (note 22)5,99065,950-(36,000)--(14,017)21,923
Share issue costs (note 22)-(300,440)-----(300,440)
Share based payment charge (note 23)----1,058,428(161,059)-897,369
Share options exercised (note 23)2,50012,550--(7,050)--8,000
Total transactions with owners1,356,8684,111,182-(36,000)1,051,378(161,059)(14,017)6,308,352
Balance as at 30 June 20263,390,2905,396,9068,333,333-2,040,5051,670,251(8,708,926)12,122,359

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Consolidated Statement of Cash Flows for the year ended 30 June 2026

NotesYear ended 30 June 2026Year ended 30 June 2025
££
Operating activities
Loss after tax(5,164,015)(14,187,288)
Adjustments for:
Foreign exchange movement on loan notes21104,717-
Finance costs893,138535,277
Share based payment expense232,890,3192,125,220
Listing costs-10,321,369
Share capital issued in exchange for costs-1,119,030
Changes in working capital:
Decrease/(Increase) in trade and other receivables1827,453(155,363)
(Decrease)/increase in trade and other payables20(12,473)19,352
Net cash outflow from operating activities(2,060,861)(222,403)
Cash flow from investing activities
Investment in exploration assets14(142,916)(151,637)
Net cash outflow from investing activities(142,916)(151,637)
Cash flow from financing activities
Proceeds from shares issued223,681,54980,311
Share issue costs22(276,940)-
Proceeds from exercise share options2315,000-
Loan interest paid8,21(93,138)(524,790)
Loan note proceeds21-752,725
Net cash inflow from financing activities3,326,471308,246
Increase/(decrease) in cash and cash equivalents1,122,694(65,794)
Cash and cash equivalents as at the beginning of the period28,42545,442
Foreign exchange on cash and cash equivalents(45,950)48,777
Cash and cash equivalents at the end of period1,105,16928,425

During the year, the Company issued share options and warrants. These transactions did not involve any cash outflows and are therefore excluded from the statement of cash flows. The fair value of the share-based payments is disclosed in note 23.

A reconciliation of net debt is set out in note 21.

The accompanying notes on pages 47 to 71 form an integral part of the financial statements.

Company Statement of Cash Flows for the year ended 30 June 2026

NotesYear ended 30 June 2026Year ended 30 June 2025
££
Operating activities
Loss after tax(4,516,303)(2,941,414)
Adjustments for:-
Foreign exchange movement on loan notes68,929-
Interest receivable on loan to subsidiaries(69,514)-
Share based payment expense232,890,3192,132,655
Share capital issued in exchange for costs-577,751
Changes in working capital
Increase in trade and other receivables18(35,454)(160,297)
Increase in trade and other payables20145,164319,325
Net cash outflow from operating activities(1,516,859)(71,980)
Cash flow from investing activities
Loan to subsidiary(1,171,616)-
Net cash flow from investing activities(1,171,616)-
Cash flow from financing activities
Proceeds from shares issued223,681,54940,000
Share issue costs22(276,940)-
Proceeds from exercise share options2315,000-
Net cash inflow from financing activities3,419,60940,000
Increase/(decrease) in cash and cash equivalents731,134(31,980)
Cash and cash equivalents as at the beginning of the period1,99133,971
Cash and cash equivalents at the end of period733,1251,991

During the year, the Company issued share options and warrants. These transactions did not involve any cash outflows and are therefore excluded from the statement of cash flows. The fair value of the share-based payments is disclosed in note 23.

The accompanying notes on pages 47 to 71 form an integral part of the financial statements

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note